Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
5,408
Views
18
CrossRef citations to date
0
Altmetric
Coronaviruses

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein

Shiqi Xua CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-0345-2814View further author information
ORCID Icon,
Yifan Wangb State Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Yanxing Wangb State Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Chao Zhanga CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-8658-9009View further author information
ORCID Icon,
Qin Hongb State Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Chenjian Guc Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Rong Xua CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Tingfeng Wanga CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Yong Yanga CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Jinkai Zanga CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Yu Zhoua CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Zuyang Lib State Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Qixing Liua CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Bingjie Zhoua CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Lulu Baia CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Yuanfei Zhuc Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;d BSL-3 Laboratory of Fudan University, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Qiang Dengc Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Haikun Wanga CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Dimitri Lavillettea CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Gary Wonga CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Youhua Xiec Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China;d BSL-3 Laboratory of Fudan University, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Yao Congb State Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Zhong Huanga CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2161-1359View further author information
ORCID Icon show all
Pages 351-367 | Received 04 Nov 2021, Accepted 28 Dec 2021, Published online: 24 Jan 2022

References

  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
  • Zhu N, Zhang DY, Wang WL, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020 Feb 20;382(8):727–733. doi: 10.1056/NEJMoa2001017
  • Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71–76. doi: 10.1016/j.ijsu.2020.02.034
  • Gorbalenya AE, Baker SC, Baric RS, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020 Apr;5(4):536–544. doi: 10.1038/s41564-020-0695-z
  • Yan RH, Zhang YY, Li YN, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 27;367(6485):1444. doi: 10.1126/science.abb2762
  • Wang Q, Zhang Y, Wu L, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020 May 14;181(4):894–904 e9. doi: 10.1016/j.cell.2020.03.045
  • Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020 May;581(7807):215–220. doi: 10.1038/s41586-020-2180-5
  • Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020 May;581(7807):221–224. doi: 10.1038/s41586-020-2179-y
  • Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr 16;181(2):281–292e6. doi: 10.1016/j.cell.2020.02.058
  • Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Mar 13;367(6483):1260–1263. doi: 10.1126/science.abb2507
  • Xu C, Wang Y, Liu C, et al. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Sci Adv. 2021 Jan;7(1):eabe5575. doi: 10.1126/sciadv.abe5575
  • Cai Y, Zhang J, Xiao T, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020 Sep 25;369(6511):1586–1592. doi: 10.1126/science.abd4251
  • Xiong X, Qu K, Ciazynska KA, et al. A thermostable, closed, SARS-CoV-2 spike protein trimer. bioRxiv.
  • Wrobel AG, Benton DJ, Xu P, et al. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat Struct Mol Biol. 2020 Aug;27(8):763–767. doi: 10.1038/s41594-020-0468-7
  • Corti D, Purcell LA, Snell G, et al. Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021 Jun 10;184(12):3086–3108. doi: 10.1016/j.cell.2021.05.005
  • Barnes CO, Jette CA, Abernathy ME, et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 2020 Dec;588(7839):682–687. doi: 10.1038/s41586-020-2852-1
  • Chi X, Yan R, Zhang J, et al. A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2. Science. 2020 Aug 7;369(6504):650–655. doi: 10.1126/science.abc6952
  • Liu L, Wang P, Nair MS, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 Aug;584(7821):450–456. doi: 10.1038/s41586-020-2571-7
  • McCallum M, De Marco A, Lempp FA, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 Apr 29;184(9):2332–2347e16. doi: 10.1016/j.cell.2021.03.028
  • Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021 Jul;19(7):409–424. doi: 10.1038/s41579-021-00573-0
  • Dejnirattisai W, Zhou D, Ginn HM, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021 Apr 15;184(8):2183–2200e22. doi: 10.1016/j.cell.2021.02.032
  • Greaney AJ, Starr TN, Gilchuk P, et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe. 2021 Jan 13;29(1):44–57e9. doi: 10.1016/j.chom.2020.11.007
  • Cerutti G, Guo Y, Zhou T, et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe. 2021 May 12;29(5):819–833e7. doi: 10.1016/j.chom.2021.03.005
  • Li D, Edwards RJ, Manne K, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 Aug 5;184(16):4203–4219 e32. doi: 10.1016/j.cell.2021.06.021
  • Jennewein MF, MacCamy AJ, Akins NR, et al. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021 Jul 13;36(2):109353. doi: 10.1016/j.celrep.2021.109353
  • Huang Y, Nguyen AW, Hsieh C-L, et al. Identification of a conserved neutralizing epitope present on spike proteins from highly pathogenic coronaviruses. bioRxiv. 2021.
  • Singh J, Rahman SA, Ehtesham NZ, et al. SARS-CoV-2 variants of concern are emerging in India. Nat Med. 2021 Jul;27(7):1131–1133. doi: 10.1038/s41591-021-01397-4
  • Martinez DR, Schafer A, Leist SR, et al. Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice. Cell Rep. 2021 Jul 27;36(4):109450. doi: 10.1016/j.celrep.2021.109450
  • Chen RE, Zhang X, Case JB, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 Apr;27(4):717–726. doi: 10.1038/s41591-021-01294-w
  • Wang L, Zhou T, Zhang Y, et al. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants. bioRxiv.
  • Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021 May;593(7857):130–135. doi: 10.1038/s41586-021-03398-2
  • Li Q, Nie J, Wu J, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 Apr 29;184(9):2362–2371e9. doi: 10.1016/j.cell.2021.02.042
  • Supasa P, Zhou D, Dejnirattisai W, et al. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021 Apr 15;184(8):2201–2211e7. doi: 10.1016/j.cell.2021.02.033
  • Williams SV, Vusirikala A, Ladhani SN, et al. An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021. Euro Surveill. 2021 Jul;26(27). https://doi.org/10.2807/1560-7917.ES.2021.26.27.2100626
  • Iacobucci G. Covid-19: Local councils initiate surge vaccination to tackle B.1.617.2 variant. Br Med J. 2021 May 25;373:n1361. doi: 10.1136/bmj.n1361
  • Dougherty K, Mannell M, Naqvi O, et al. SARS-CoV-2 B.1.617.2 (delta) variant COVID-19 outbreak associated with a gymnastics facility – Oklahoma, April–May 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):1004–1007. doi: 10.15585/mmwr.mm7028e2
  • Zhang C, Wang Y, Zhu Y, et al. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nat Commun. 2021 Jan 11;12(1):264. doi: 10.1038/s41467-020-20465-w
  • Rong Z, Zhigang Y, Yuyan W, et al. Isolation of a 2019 novel coronavirus strain from a coronavirus disease 19 patient in Shanghai. Journal of Microbes and Infections. 2020;15(1):111–121.
  • Yang Y, Zang J, Xu S, et al. Elicitation of broadly neutralizing antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 variants by three prototype strain-derived recombinant protein vaccines. Viruses. 2021 Jul 22;13(8):1421. doi: 10.3390/v13081421
  • Qu P, Zhang C, Li M, et al. A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein. Cell Discov. 2020 2020/02/04;6(1):5. doi: 10.1038/s41421-019-0140-8
  • Zhang C, Xu C, Dai W, et al. Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections. Nat Commun. 2021 May 18;12(1):2904. doi: 10.1038/s41467-021-23199-5
  • Ye J, Ma N, Madden TL, et al. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34–W40. doi: 10.1093/nar/gkt382
  • Yi Y, Wang S, Wang X, et al. Identification of human norovirus GII.3 blockade antibody epitopes. Viruses. 2021 Oct 13;13(10):2058. doi: 10.3390/v13102058
  • Giroglou T, Cinatl Jr J, Rabenau H, et al. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol. 2004 Sep;78(17):9007–9015. doi: 10.1128/JVI.78.17.9007-9015.2004
  • Dieterle ME, Haslwanter D, Bortz III RH, et al. A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition. Cell Host Microbe. 2020 Sep 9;28(3):486–496e6. doi: 10.1016/j.chom.2020.06.020
  • Zheng SQ, Palovcak E, Armache JP, et al. Motioncor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017 Apr;14(4):331–332. doi: 10.1038/nmeth.4193
  • Zivanov J, Nakane T, Forsberg BO, et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife. 2018 Nov 9;7. https://doi.org/10.7554/eLife.42166
  • Rohou A, Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J Struct Biol. 2015 Nov;192(2):216–221. doi: 10.1016/j.jsb.2015.08.008
  • Punjani A, Rubinstein JL, Fleet DJ, et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017 Mar;14(3):290–296. doi: 10.1038/nmeth.4169
  • Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252–W258. doi: 10.1093/nar/gku340
  • Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta crystallographica section D. Biol Crystall. 2004 Dec;60(Pt 12 Pt 1):2126–2132. doi: 10.1107/S0907444904019158
  • Pettersen EF, Goddard TD, Huang CC, et al. UCSF chimera–a visualization system for exploratory research and analysis. J Comput Chem. 2004 Oct;25(13):1605–1612. doi: 10.1002/jcc.20084
  • DiMaio F, Song Y, Li X, et al. Atomic-accuracy models from 4.5-A cryo-electron microscopy data with density-guided iterative local refinement. Nat Methods. 2015 Apr;12(4):361–365. doi: 10.1038/nmeth.3286
  • Adams PD, Afonine PV, Bunkoczi G, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213–221. doi: 10.1107/S0907444909052925
  • Goddard TD, Huang CC, Meng EC, et al. UCSF chimerax: meeting modern challenges in visualization and analysis. Protein Sci. 2018 Jan;27(1):14–25. doi: 10.1002/pro.3235
  • Wang Y, Xu C, Wang Y, et al. Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM. Nat Commun. 2021 Dec 12;12(1):7345. doi: 10.1038/s41467-021-27350-0
  • Li D, Sempowski GD, Saunders KO, et al. SARS-CoV-2 neutralizing antibodies for COVID-19 prevention and treatment. Annu Rev Med. 2021 Aug 24. https://doi.org/10.1146/annurev-med-042420-113838
  • Hastie KM, Li H, Bedinger D, et al. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: a global consortium study. Science. 2021 Oct 22;374(6566):472–478. doi: 10.1126/science.abh2315
  • Tortorici MA, Beltramello M, Lempp FA, et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 Nov 20;370(6519):950–957. doi: 10.1126/science.abe3354
  • van Dorp L, Tan CC, Lam SD, et al. Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation. BioRxiv.
  • Interactive Real-Time Mutation Tracker. Available from: https://users.math.msu.edu/users/weig/SARS-CoV-2_Mutation_Tracker.html
  • Li D, Edwards RJ, Manne K, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 Aug 5;184(16):4203–4219e32. doi: 10.1016/j.cell.2021.06.021
  • Huang Y, Nguyen AW, Hsieh C-L, et al. Identification of a conserved neutralizing epitope present on spike proteins from highly pathogenic coronaviruses. BioRxiv. 2021.
  • Pinto D, Sauer MM, Czudnochowski N, et al. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 Sep 3;373(6559):1109–1116. doi: 10.1126/science.abj3321

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.